x

Posted 08 February, 2024

Kyverna Therapeutics, Inc. IPO completed

IPO completed detected for ticker Nasdaq:KYTX in a 424B4 filed on 08 February, 2024.


  This is an initial public offering of shares of common stock of Kyverna Therapeutics, Inc.  

Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Kyverna Therapeutics, Inc.
Health Care/Life Sciences • Biotechnology
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Market Cap
$115M
View Company Details